Related Experiment Video
Updated: Apr 21, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Oxidative DNA Damage Response in Helicobacter pylori-Infected Mongolian Gerbils
Minkyung Bae1, Joo Weon Lim1, Hyeyoung Kim1
1Department of Food and Nutrition, Brian Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Abstract:
Helicobacter pylori (H. pylori) induced DNA damage which may be related to gastric cancer development. The DNA damage response coordinates DNA repair, cell-cycle transition, and apoptosis through activation of DNA damage response molecules. The damaged DNA is repaired through non-homologous end joining (NHEJ) or homologous recombination (HR). In the present study, we investigated the changes of HR DNA repair proteins (ataxia-telangiectasia-mutated; ATM, ATM and Rad3-related; ATR), NHEJ repair proteins (Ku70/80), cell cycle regulators (Chk1, Chk2), and apoptosis marker (p53/p-p53) were determined in H. pylori-infected Mongolian gerbils. In addition, the effect of an antioxidant N-acetylcysteine (NAC) on H. pylori-induced DNA damage response was determined to assess the involvement of oxidative stress on DNA damage of the animals infected with H. pylori. One week after intragastric inoculation with H. pylori, Mongolian gerbils were fed with basal diet with or without 3% NAC for 6 weeks. After 6 week, the expression levels of DNA repair proteins (Ku70/80, ATM, ATR), cell cycle regulators (Chk1, Chk2) and apoptosis marker (p-p53/p53) were increased in gastric mucosa of Mongolian gerbils, which was suppressed by NAC treatment. In conclusion, oxidative stress mediates H. pylori-induced DNA damage response including NHEJ and HR repairing processes, cell cycle arrest and apoptosis in gastric mucosa of Mongolian gerbils.
Insights
Helicobacter pylori infection causes DNA damage in gerbil stomachs, activating repair and cell death pathways. The antioxidant N-acetylcysteine (NAC) mitigated this damage, suggesting oxidative stress involvement in H. pylori-induced gastric issues.
Area of Science:
- Gastroenterology
- Molecular Biology
- Cancer Research
Background:
- Helicobacter pylori (H. pylori) infection is a known risk factor for gastric cancer.
- H. pylori-induced DNA damage is implicated in gastric carcinogenesis.
- DNA damage response pathways, including repair, cell cycle regulation, and apoptosis, are crucial in maintaining genomic stability.
Purpose of the Study:
- To investigate the impact of H. pylori infection on DNA damage response pathways in Mongolian gerbils.
- To determine the role of oxidative stress in H. pylori-induced DNA damage.
- To evaluate the protective effect of N-acetylcysteine (NAC) against H. pylori-induced DNA damage.
Main Methods:
- Mongolian gerbils were infected with H. pylori and treated with or without N-acetylcysteine (NAC) for 6 weeks.
- Expression levels of key DNA repair proteins (ATM, ATR, Ku70/80), cell cycle regulators (Chk1, Chk2), and apoptosis markers (p53/p-p53) were analyzed in gastric mucosa.
- Assessment of H. pylori-induced DNA damage response and the effect of NAC.
Main Results:
- H. pylori infection significantly increased the expression of DNA repair proteins (ATM, ATR, Ku70/80), cell cycle regulators (Chk1, Chk2), and apoptosis markers (p53/p-p53) in gerbil gastric mucosa.
- Treatment with NAC suppressed the H. pylori-induced elevation of these DNA damage response markers.
- These findings indicate that oxidative stress plays a mediating role in H. pylori-induced DNA damage.
Conclusions:
- Oxidative stress is a key mechanism underlying H. pylori-induced DNA damage response in the gastric mucosa.
- H. pylori infection triggers both non-homologous end joining (NHEJ) and homologous recombination (HR) DNA repair pathways, alongside cell cycle arrest and apoptosis.
- NAC demonstrates a potential therapeutic role by mitigating H. pylori-induced DNA damage, likely through its antioxidant properties.
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

